Latest News about GSK
Recent news which mentions GSK
GSK, Pfizer Lock Horns Over Patent Fight Related To Respiratory Syncytial Virus Vaccine
August 02, 2023
From Benzinga
GSK's Jemperli Plus Chemo Combo Scores FDA Approval As First New Frontline Treatment For Certain Type Of Endometrial Cancer
August 01, 2023
Tickers
GSK
From Benzinga
From InvestorPlace
From InvestorPlace
Is GSK Stock Worth Buying Right Now?
July 29, 2023
From Motley Fool
GSK Says 'Excellent' Q2 Performance Boosted By Vaccine & HIV Drug Sales, Raises 2023 Outlook
July 26, 2023
Tickers
GSK
From Benzinga
From Benzinga
GSK-Pfizer Backed HIV-Focused Unit ViiV Healthcare's Cabotegravir Injected Drug, Tablets Secure European Backing For Approval
July 24, 2023
From Benzinga
From InvestorPlace
Why Shares of Vir Biotechnology Are Plunging Thursday
July 20, 2023
From Motley Fool
Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business
July 13, 2023
From Benzinga
Tags
TWLO
NYSE:SE,NASDAQ:ALEC,NYSE:ASAN,NASDAQ:OKTA,NYSE:TWLO,NYSE:TDOC,NYSE:U,NYSE:GSK,NYSE:ABBV,NASDAQ:BIIB
BIIB
From InvestorPlace
3 Healthcare Stocks With Healthy Dividends
July 13, 2023
From Motley Fool
3 No-Brainer Stocks to Buy With $50 Right Now
July 12, 2023
From Motley Fool
Why Are NanoViricides Shares Gaining Today
July 11, 2023
From Benzinga
From Benzinga
GSK's RSV Vaccine Scores Approval In UK For Older Adults
July 10, 2023
From Benzinga
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
July 07, 2023
From Benzinga
Analyst Creates Bullish Pitch For WAVE Life Sciences, Says It Is 'Leader To Clinic In RNA Editing'
July 05, 2023
From Benzinga
Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit
July 05, 2023
From Benzinga
Moderna Initiates Regulatory Application Process Seeking Approval For Its RSV Vaccine In Older Adults
July 05, 2023
From Benzinga
Haleon Contemplates Sale of Non-Core Businesses, Including Nicotinell Brand: A Strategy Shift Towards Core Products
July 05, 2023
From Benzinga
First US Trial Over Zantac's Alleged Cancer-Causing Properties Set For November In California
July 03, 2023
From Benzinga
Better Artificial Intelligence Stock: GSK or Eli Lilly?
June 28, 2023
From Motley Fool
From Benzinga
Second Most Prevalent Bacterial Sexually Transmitted Infection: GSK's Gonorrhea Vaccine Secures FDA Track
June 27, 2023
Tickers
GSK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.